OPN1MW2
geneOn this page
Summary
OPN1MW2 (opsin 1, medium wave sensitive 2, HGNC:26952) is a protein-coding gene on chromosome Xq28, encoding Medium-wave-sensitive opsin 2 (P0DN77). Visual pigments are the light-absorbing molecules that mediate vision.
This gene encodes for a light absorbing visual pigment of the opsin gene family. The encoded protein is called green cone photopigment or medium-wavelength sensitive opsin. Opsins are G-protein coupled receptors with seven transmembrane domains, an N-terminal extracellular domain, and a C-terminal cytoplasmic domain. The long-wavelength opsin gene and multiple copies of the medium-wavelength opsin gene are tandemly arrayed on the X chromosome and frequent unequal recombination and gene conversion may occur between these sequences. X chromosomes may have fusions of the medium- and long-wavelength opsin genes or may have more than one copy of these genes. Defects in this gene are the cause of deutanopic colorblindness.
Source: NCBI Gene 728458 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 30 total — 3 pathogenic
- MANE Select transcript:
NM_001048181
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26952 |
| Approved symbol | OPN1MW2 |
| Name | opsin 1, medium wave sensitive 2 |
| Location | Xq28 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000166160 |
| Ensembl biotype | protein_coding |
| Entrez | 728458 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000369929, ENST00000430419, ENST00000488220
RefSeq mRNA: 1 — MANE Select: NM_001048181
NM_001048181
CCDS: CCDS35447
Canonical transcript exons
ENST00000369929 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001775155 | 154230548 | 154230787 |
| ENSE00001804493 | 154228828 | 154228993 |
| ENSE00001836079 | 154233070 | 154233286 |
| ENSE00001937441 | 154219756 | 154219927 |
| ENSE00003569555 | 154224908 | 154225204 |
| ENSE00003664302 | 154227192 | 154227360 |
Expression profiles
Bgee: expression breadth tissue_specific, 4 present calls, max score 46.18.
Top tissues by expression
106 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 46.18 | silver quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| vermiform appendix | UBERON:0001154 | 35.62 | silver quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| bone marrow | UBERON:0002371 | 35.06 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| muscle tissue | UBERON:0002385 | 32.44 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.35 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 28.73 | silver quality |
| liver | UBERON:0002107 | 28.57 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| urinary bladder | UBERON:0001255 | 27.65 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| skin of leg | UBERON:0001511 | 26.62 | silver quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| muscle of leg | UBERON:0001383 | 26.53 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
| zone of skin | UBERON:0000014 | 25.96 | silver quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
| placenta | UBERON:0001987 | 25.81 | gold quality |
| gastrocnemius | UBERON:0001388 | 25.60 | gold quality |
| leukocyte | CL:0000738 | 25.26 | gold quality |
| monocyte | CL:0000576 | 25.03 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
13 targeting OPN1MW2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4534 | 99.99 | 66.58 | 1907 |
| HSA-MIR-96-5P | 99.95 | 72.80 | 2140 |
| HSA-MIR-12133 | 99.92 | 71.82 | 2006 |
| HSA-MIR-1271-5P | 99.91 | 71.99 | 1972 |
| HSA-MIR-182-5P | 99.87 | 74.03 | 2589 |
| HSA-MIR-577 | 99.78 | 69.13 | 2479 |
| HSA-MIR-6794-5P | 99.76 | 66.38 | 1048 |
| HSA-MIR-4716-3P | 99.69 | 66.73 | 1022 |
| HSA-MIR-4729 | 99.69 | 72.18 | 4233 |
| HSA-MIR-4516 | 99.61 | 67.78 | 3390 |
| HSA-MIR-5703 | 99.10 | 67.09 | 2053 |
| HSA-MIR-4434 | 99.10 | 67.01 | 1984 |
| HSA-MIR-625-5P | 99.02 | 68.64 | 2031 |
Literature-anchored findings (GeneRIF, showing 1)
- Immunoreactivity to anti-OPN1LW antibodies was seen in the basal layer of human epidermis & reconstructed skin. The opsin mRNA was seen in total RNA from human skin. Neither immunoreactivity nor mRNA expression was seen in cultured human keratinocytes. (PMID:19493002)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | opn1lw2 | ENSDARG00000044861 |
| danio_rerio | opn1lw1 | ENSDARG00000044862 |
| mus_musculus | Opn1mw | ENSMUSG00000031394 |
| rattus_norvegicus | Opn1mw | ENSRNOG00000051529 |
Paralogs (9): OPN3 (ENSG00000054277), OPN1LW (ENSG00000102076), OPN4 (ENSG00000122375), OPN5 (ENSG00000124818), OPN1SW (ENSG00000128617), RHO (ENSG00000163914), RRH (ENSG00000180245), OPN1MW (ENSG00000268221), OPN1MW3 (ENSG00000269433)
Protein
Protein identifiers
Medium-wave-sensitive opsin 2 — P0DN77 (reviewed: P0DN77)
Alternative names: Green cone photoreceptor pigment, Green-sensitive opsin, Opsin 1 cone pigments medium-wave-sensitive 2
All UniProt accessions (2): P0DN77, H0Y642
UniProt curated annotations — full annotation on UniProt →
Function. Visual pigments are the light-absorbing molecules that mediate vision. They consist of an apoprotein, opsin, covalently linked to cis-retinal.
Subcellular location. Cell membrane.
Post-translational modifications. N-glycosylated. O-glycosylated. Phosphorylated on some or all of the serine and threonine residues present in the C-terminal region.
Similarity. Belongs to the G-protein coupled receptor 1 family. Opsin subfamily.
RefSeq proteins (1): NP_001041646* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000378 | Opsin_red/grn | Family |
| IPR001760 | Opsin | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
| IPR027430 | Retinal_BS | Binding_site |
| IPR050125 | GPCR_opsins | Family |
Pfam: PF00001
UniProt features (21 total): topological domain 8, transmembrane region 7, region of interest 2, chain 1, modified residue 1, glycosylation site 1, disulfide bond 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P0DN77-F1 | 82.82 | 0.56 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 312
Disulfide bonds (1): 126–203
Glycosylation sites (1): 34
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 41 (showing top):
GOBP_CELLULAR_RESPONSE_TO_LIGHT_STIMULUS, GOBP_PHOTOTRANSDUCTION, GOBP_CYTOKINESIS, GOBP_POSITIVE_REGULATION_OF_CELL_DIVISION, GOBP_SENSORY_PERCEPTION_OF_LIGHT_STIMULUS, GOBP_REGULATION_OF_CELL_CYCLE, GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_PROCESS, GOBP_REGULATION_OF_CYTOKINESIS, GOBP_POSITIVE_REGULATION_OF_CYTOKINESIS, GOBP_REGULATION_OF_CELL_DIVISION, GOBP_RESPONSE_TO_RADIATION, GOBP_DETECTION_OF_LIGHT_STIMULUS, GOBP_RESPONSE_TO_ABIOTIC_STIMULUS, GOBP_DETECTION_OF_ABIOTIC_STIMULUS, GOBP_DETECTION_OF_STIMULUS
GO Biological Process (8): G protein-coupled receptor signaling pathway (GO:0007186), visual perception (GO:0007601), phototransduction (GO:0007602), absorption of visible light (GO:0016038), positive regulation of cytokinesis (GO:0032467), cellular response to light stimulus (GO:0071482), signal transduction (GO:0007165), detection of visible light (GO:0009584)
GO Molecular Function (3): G protein-coupled photoreceptor activity (GO:0008020), G protein-coupled receptor activity (GO:0004930), photoreceptor activity (GO:0009881)
GO Cellular Component (4): photoreceptor outer segment (GO:0001750), plasma membrane (GO:0005886), photoreceptor disc membrane (GO:0097381), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| G protein-coupled receptor activity | 2 |
| signal transduction | 2 |
| detection of light stimulus | 2 |
| cellular anatomical structure | 2 |
| sensory perception of light stimulus | 1 |
| light absorption | 1 |
| cytokinesis | 1 |
| regulation of cytokinesis | 1 |
| positive regulation of cell division | 1 |
| positive regulation of cell cycle process | 1 |
| response to light stimulus | 1 |
| cellular response to radiation | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| detection of visible light | 1 |
| photoreceptor activity | 1 |
| transmembrane signaling receptor activity | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| signaling receptor activity | 1 |
| photoreceptor cell cilium | 1 |
| membrane | 1 |
| cell periphery | 1 |
| photoreceptor outer segment | 1 |
| organelle membrane | 1 |
Protein interactions and networks
STRING
346 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OPN1MW2 | TEX28 | O15482 | 507 |
| OPN1MW2 | GUCA1C | O95843 | 502 |
| OPN1MW2 | CRYAA | P02489 | 444 |
| OPN1MW2 | OR51D1 | Q8NGF3 | 430 |
| OPN1MW2 | GNAT2 | P19087 | 417 |
| OPN1MW2 | OR52J3 | Q8NH60 | 373 |
| OPN1MW2 | GRAPL | Q8TC17 | 350 |
| OPN1MW2 | CCDC66 | A2RUB6 | 348 |
| OPN1MW2 | NR2E3 | Q9Y5X4 | 312 |
| OPN1MW2 | GNAT1 | P11488 | 291 |
| OPN1MW2 | SEC61A2 | Q9H9S3 | 287 |
| OPN1MW2 | ARR3 | P36575 | 284 |
| OPN1MW2 | VSX1 | Q9NZR4 | 283 |
| OPN1MW2 | TMX3 | Q96JJ7 | 272 |
| OPN1MW2 | RCVRN | P35243 | 263 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: O12948, O18910, O18912, O18913, O18914, O35476, O35478, O35599, O57605, O93441, O93459, P04000, P04001, P0DN77, P0DN78, P22329, P22330, P22331, P22332, P22671, P28683, P32309, P32310, P32311, P32312, P32313, P34989, P35357, P35358, P41591, P41592, P51471, P51472, P51474, P51488, P79863, P87365, P87366, P87367, Q8AYM7
Diamond homologs: O12948, O13092, O13227, O18910, O18911, O18912, O18913, O18914, O35476, O35478, O35599, O42604, O57605, O62794, O93441, O93459, P03999, P04000, P04001, P0DN77, P0DN78, P22328, P22329, P22330, P22331, P22332, P22671, P28683, P28684, P32308, P32309, P32310, P32311, P32312, P32313, P34989, P35357, P35358, P35359, P35403
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
30 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 3 |
| Likely pathogenic | 0 |
| Uncertain significance | 19 |
| Likely benign | 8 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (3)
| Variant ID | HGVS | Classification |
|---|---|---|
| 1526876 | GRCh37/hg19 Xq28(chrX:153113943-153624020) | Pathogenic |
| 441742 | GRCh37/hg19 Xq28(chrX:153097608-153681801)x2 | Pathogenic |
| 536592 | NC_000023.10:g.(?153295726)(153786885_?)dup | Pathogenic |
SpliceAI
899 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:154219925:GAG:G | donor_gain | 1.0000 |
| X:154219926:AGG:A | donor_loss | 1.0000 |
| X:154219927:GGT:G | donor_loss | 1.0000 |
| X:154219928:GTGA:G | donor_loss | 1.0000 |
| X:154227190:A:AG | acceptor_gain | 1.0000 |
| X:154227191:G:GG | acceptor_gain | 1.0000 |
| X:154227357:GCAG:G | donor_gain | 1.0000 |
| X:154227358:CAG:C | donor_loss | 1.0000 |
| X:154227358:CAGGT:C | donor_loss | 1.0000 |
| X:154227359:AGG:A | donor_loss | 1.0000 |
| X:154227360:GGTA:G | donor_loss | 1.0000 |
| X:154227361:G:A | donor_loss | 1.0000 |
| X:154227362:T:G | donor_loss | 1.0000 |
| X:154228822:CTCCA:C | acceptor_loss | 1.0000 |
| X:154228823:TCCA:T | acceptor_loss | 1.0000 |
| X:154228823:TCCAG:T | acceptor_loss | 1.0000 |
| X:154228824:CCA:C | acceptor_loss | 1.0000 |
| X:154228825:CA:C | acceptor_loss | 1.0000 |
| X:154228825:CAG:C | acceptor_loss | 1.0000 |
| X:154228826:AGGT:A | acceptor_loss | 1.0000 |
| X:154228826:AGGTA:A | acceptor_loss | 1.0000 |
| X:154228827:G:GT | acceptor_loss | 1.0000 |
| X:154228991:GCG:G | donor_gain | 1.0000 |
| X:154230545:TAGGT:T | acceptor_loss | 1.0000 |
| X:154230785:CAGGT:C | donor_loss | 1.0000 |
| X:154230787:GGTA:G | donor_loss | 1.0000 |
| X:154230787:GGTAA:G | donor_loss | 1.0000 |
| X:154230788:GT:G | donor_loss | 1.0000 |
| X:154230788:GTA:G | donor_loss | 1.0000 |
| X:154230789:T:G | donor_loss | 1.0000 |
AlphaMissense
2391 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1065427 (X:154230623 G>A), RS1065430 (X:154230626 C>T), RS1065432 (X:154230628 G>T), RS1065433 (X:154230631 A>C,G), RS1065434 (X:154230633 T>A), RS1065436 (X:154230638 T>C,G), RS1065437 (X:154230652 C>A,T), RS1065438 (X:154230656 G>A), RS112842419 (X:154223865 G>T), RS112920784 (X:154224227 G>A), RS113348300 (X:154218538 G>T), RS1196431422 (X:154217788 T>A), RS1219012335 (X:154218027 T>A,G), RS1260349389 (X:154218006 C>A), RS1273502906 (X:154218033 G>A)
Disease associations
OMIM: gene `` | disease phenotypes: MIM:300049, MIM:304120, MIM:309350, MIM:305620, MIM:300673
GenCC curated gene-disease
Mondo (5): heterotopia, periventricular, X-linked dominant (MONDO:0010233), otopalatodigital syndrome type 2 (MONDO:0010571), Melnick-Needles syndrome (MONDO:0010650), frontometaphyseal dysplasia (MONDO:0015942), severe neonatal-onset encephalopathy with microcephaly (MONDO:0010397)
Orphanet (7): Frontometaphyseal dysplasia (Orphanet:1826), Nodular neuronal heterotopia (Orphanet:2149), Melnick-Needles syndrome (Orphanet:2484), OBSOLETE: Otopalatodigital syndrome (Orphanet:669), Ehlers-Danlos syndrome with periventricular heterotopia (Orphanet:82004), Otopalatodigital syndrome type 2 (Orphanet:90652), MECP2-related severe neonatal encephalopathy (Orphanet:209370)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST90002381_504 | Eosinophil count | 2.000000e-11 |
| GCST90002382_524 | Eosinophil percentage of white cells | 1.000000e-17 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004842 | eosinophil count |
| EFO:0007991 | eosinophil percentage of leukocytes |
MeSH disease descriptors (3)
| Descriptor | Name | Tree numbers |
|---|---|---|
| C566878 | Encephalopathy, Neonatal Severe, Due To Mecp2 Mutations (supp.) | |
| C538064 | Frontometaphyseal dysplasia (supp.) | |
| C538089 | Oto-palato-digital syndrome, type 2 (supp.) |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
Clinical trials (associated diseases)
6 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT05857085 | PHASE4 | COMPLETED | Novel Therapeutics and Endothelial Dysfunction in T1DM Patients |
| NCT06547216 | PHASE2 | ACTIVE_NOT_RECRUITING | Phase 2 Open-label Extension Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) |
| NCT05747924 | PHASE1/PHASE2 | COMPLETED | Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) |
| NCT01862146 | Not specified | COMPLETED | Arterial Remodeling in Smokers |
| NCT02127333 | Not specified | COMPLETED | Role of Oxygen for Vascular Dysfunction |
| NCT04199949 | Not specified | COMPLETED | Effects of Five Days of Physical Inactivity on Endothelial Function in Healthy Humans |
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): frontometaphyseal dysplasia, heterotopia, periventricular, X-linked dominant, Melnick-Needles syndrome, otopalatodigital syndrome type 2, severe neonatal-onset encephalopathy with microcephaly